LOADING
Tag: Stock
This biopharma stock could more than double on oral eczema treatment, Goldman Sachs says – CNBC
April 17, 2026
This biopharma stock could more than double on oral eczema treatment, Goldman Sachs says CNBC Source link
chat_bubble0 Comment
visibility9 Views
Johnson & Johnson Stock (JNJ) Update: Shares Hold Near $208 as Markets Close for the Weekend; Eczema Trial Halt, Pipeline Wins, and 2026 Outlook in Focus – ts2.tech
December 28, 2025
Johnson & Johnson Stock (JNJ) Update: Shares Hold Near $208 as Markets Close for the Weekend; Eczema Trial Halt, Pipeline Wins, and 2026 Outlook in Focus ts2.tech Source link
chat_bubble0 Comment
visibility67 Views
Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September – The Globe and Mail
October 5, 2025
Here’s Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September The Globe and Mail Source link
chat_bubble0 Comment
visibility73 Views